Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes

Details for Australian Patent Application No. 2006254796 (hide)

Owner Amicus Therapeutics, Inc.

Inventors Wustman, Brandon

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2006254796

PCT Pub. Number WO2006/133446

Priority 60/689,120 08.06.05 US

Filing date 8 June 2006

Wipo publication date 14 December 2006

Acceptance publication date 16 August 2012

International Classifications

A01N 43/40 Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/445 - Non-condensed piperidines, e.g. piperocaine

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/133446 Priority application(s): WO2006/133446

16 August 2012 Application Accepted

  Published as AU-B-2006254796

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006254809-Indane derivatives as modulators of ion channels

2006254794-Increase of stress tolerance by application of neonicotinoids on plants engineered to be stress tolerant